Furthermore, characterization of the dermal infiltrate reveals that HS lesions have a preponderance of CD3+ and CD31+ cells compared with NS, suggesting a role of chronic inflammation and abnormalities in vascularization. The gene discussed is PECAM1; the disease is histiocytic sarcoma.